(b)(4).Occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Investigation summary: no device associated with this report was received for examination.This hip replacement platform was voluntarily recalled from the market and the product codes are now considered inactive.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Addendum added (b)(6) 2020.Following further review, it was identified that this was an asr product.The asr platform was voluntarily recalled from the market in (b)(6) 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.Ref.(b)(4) superseded by (b)(4).
|
patient had s depuy asr total acetabular implant.The letter alleges pain, functional limitations, rise in chromium and cobalt ions in blood and urine, articular crepitation and distress.The patient then underwent right hip revision surgery and it was observed that there was rough ossification departing from the femoral neck up to the acetabulum, brownish fluid and metallosis.Histological examination indicates chronic non-specific synovitis with an area of sclerosis and meta-hemorrhage foci.Added lawyer, patient date of birth, patient sex, date of implant, operative hip, patient harms, date of explant/event date, implant duration, patient and pe codes, revising surgeon and surgeon.Doi: (b)(6) 2007 - dor: (b)(6) 2015 (right hip).
|